Palunsod, Rosita D.
HRN: 26-10-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/20/2024
10/26/2024
IV
2.25g
Q8h
Urosepsis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes